Next Article in Journal
Microencapsulation of Purple Cactus Pear Fruit (Opuntia ficus indica) Extract by the Combined Method W/O/W Double Emulsion-Spray Drying and Conventional Spray Drying: A Comparative Study
Next Article in Special Issue
A Newly Designed EGFP-2A Peptide Monocistronic Baculoviral Vector for Concatenating the Expression of Recombinant Proteins in Insect Cells
Previous Article in Journal
A Novel Framework for Parameter and State Estimation of Multicellular Systems Using Gaussian Mixture Approximations
Article

Non-Viral Transfection of Human T Lymphocytes

1
Process Biotechnology, University of Bayreuth, 95440 Bayreuth, Germany
2
Agap2—HIQ Consulting GmbH, 60323 Frankfurt am Main, Germany
3
Department Synthesis of Macromolecules, Max Planck Institute for Polymer Research, 55128 Mainz, Germany
*
Author to whom correspondence should be addressed.
Processes 2018, 6(10), 188; https://doi.org/10.3390/pr6100188
Received: 10 September 2018 / Revised: 27 September 2018 / Accepted: 9 October 2018 / Published: 11 October 2018
(This article belongs to the Special Issue Transient Gene Expression for Rapid Protein and Virus-Vector Supply)
The genetic modification of human T lymphocytes with established non-viral methods is inefficient. Linear polyethylenimine (l-PEI), one of the most popular non-viral transfection agents for mammalian cells in general, only achieves transfection rates in the single digit percentage range for these cells. Here, a well-defined 24-armed poly(2-dimethylamino) ethyl methacrylate (PDMAEMA) nanostar (number average of the molecular weight: 755 kDa, polydispersity: <1.21) synthesized via atom transfer radical polymerization (ATRP) from a silsesquioxane initiator core is proposed as alternative. The agent is used to prepare polyplexes with plasmid DNA (pDNA). Under optimal conditions these polyplexes reproducibly transfect >80% of the cells from a human T-cell leukemia cell line (Jurkat cells) at viabilities close to 90%. The agent also promotes pDNA uptake when simply added to a mixture of cells and pDNA. This constitutes a particular promising approach for efficient transient transfection at large scale. Finally, preliminary experiments were carried out with primary T cells from two different donors. Results were again significantly better than for l-PEI, although further research into the response of individual T cells to the transfection agent will be necessary, before either method can be used to routinely transfect primary T lymphocytes. View Full-Text
Keywords: non-viral gene delivery; Jurkat cells; human T lymphocytes; primary cells; poly(2-dimethylamino) ethyl methacrylate; polycation; nanostar non-viral gene delivery; Jurkat cells; human T lymphocytes; primary cells; poly(2-dimethylamino) ethyl methacrylate; polycation; nanostar
Show Figures

Graphical abstract

MDPI and ACS Style

Riedl, S.A.B.; Kaiser, P.; Raup, A.; Synatschke, C.V.; Jérôme, V.; Freitag, R. Non-Viral Transfection of Human T Lymphocytes. Processes 2018, 6, 188. https://doi.org/10.3390/pr6100188

AMA Style

Riedl SAB, Kaiser P, Raup A, Synatschke CV, Jérôme V, Freitag R. Non-Viral Transfection of Human T Lymphocytes. Processes. 2018; 6(10):188. https://doi.org/10.3390/pr6100188

Chicago/Turabian Style

Riedl, Simon A.B., Patrick Kaiser, Alexander Raup, Christopher V. Synatschke, Valérie Jérôme, and Ruth Freitag. 2018. "Non-Viral Transfection of Human T Lymphocytes" Processes 6, no. 10: 188. https://doi.org/10.3390/pr6100188

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop